Abstract
The whole body I-131 scan is routinely performed in the postoperative treatment of patients with well-differentiated thyroid cancer. Accurate interpretation of whole body I-131 scan after thyroidectomy is critical to appropriate management of patients with thyroid cancer, to prevent unnecessary surgical removal or exposure to radioiodine. Unfortunately, false-positive uptakes in several other organs and their associated disease processes have been reported. We report a case of false-positive iodine uptake in the pelvic region with incidentally diagnosed mature cystic teratoma.
This is a preview of subscription content, log in via an institution to check access.
References
Brown AP, Greening WP, McCready VR, Shaw HJ, Harmer CL. Radioiodine treatment of metastatic thyroid carcinoma: the Royal Marsden Hospital experience. Br J Radiol. 1984;57(676):323–7.
Filetti S, Bidart JM, Arturi F, Caillou B, Russo D, Schlumberger M. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism. Eur J Endocrinol. 1999;141(5):443–57.
Carlisle MR, Lu C, McDougall IR. The interpretation of 131I scans in the evaluation of thyroid cancer, with an emphasis on false positive findings. Nucl Med Commun. 2003;24(6):715–35.
Shapiro B, Rufini V, Jarwan A, Geatti O, Kearfott KJ, Fig LM, et al. Artifacts, anatomical and physiological variants, and unrelated diseases that might cause false-positive whole-body 131-I scans in patients with thyroid cancer. Semin Nucl Med. 2000;30(2):115–32.
Byeong-Cheol Ahn. Physiologic and False Positive Pathologic Uptakes on Radioiodine whole Body Scan. In: Rongfu Wang editor. 12 Chapters on Nuclear Medicine. Kindle edition. Intech ; 2012. p.1–24.
Nair N, Basu S, Pakhale H. Unusual uptake of radioiodine in the chest in a patient with thyroid carcinoma. Br J Radiol. 2004;77(913):63–7.
Riesco–Eizaguirre G, Santisteban P. A perspective view of sodium iodide symporter research and its clinical implications. Eur J Endocrinol. 2006;155(4):495–512.
Ghander C, Lussato D, Conte Devolx B, Mundler O, Taieb D. Incidental diagnosis of struma ovarii after thyroidectomy for thyroid cancer: functional imaging studies and follow-up. Gynecol Oncol. 2006;102(2):378–80.
Utsunomiya D, Shiraishi S, Kawanaka K, Lwakatare F, Tomiguchi S, Kido R, et al. Struma ovarii coexisting with mucinous cystadenoma detected by radioactive iodine. Clin Nucl Med. 2003;28(9):725–7.
Song HJ, Xue YL, Xu YH, Qiu ZL, Luo QY. Abnormal 131I uptake in a benign serous ovarian cystadenoma mimicking bladder physiological uptake. Clin Nucl Med. 2012;37(3):e59–60.
Lungo M, Tenenbaum F, Chaumerliac P, Vons C, Mirat A, Beuzen F, et al. Ovarian endometriosis cyst with iodine 131 uptake: first case of false positive in the follow up for differentiated thyroid carcinoma. Ann Endocrinol (Paris). 2000;61(2):147–50.
Logani S, Baloch ZW, Snyder PJ, Weinstein R, LiVolsi VA. Cystic ovarian metastasis from papillary thyroid carcinoma: a case report. Thyroid. 2001;11(11):1073–5.
Makani S, Kim W, Gab AR. Struma Ovarii with a focus of papillary thyroid cancer: a case report and review of the literature. Gynecol Oncol. 2004;94(3):835–9.
Matsuda K, Maehama T, Kanazawa K. Malignant Struma Ovarii with Thyrotoxicosis. Gynecol Oncol. 2001;82(3):575–7.
Outwater EK, Siegelman ES, Hunt JL. Ovarian teratomas: tumor types and imaging characteristics. Radiographics. 2001;21(2):475–90.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yoon, S., soo Hong, I. Ovarian Teratoma Mimicking Metastasis on I-131 Scan : A Case Report. Nucl Med Mol Imaging 47, 52–54 (2013). https://doi.org/10.1007/s13139-012-0167-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13139-012-0167-3